Nf Κb P105 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{Infobox gene}}
NFKB1 PROTEIN is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of NFKB1 PROTEIN is associated with neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, and related disorders.
The NFKB1 gene encodes the p105 subunit of Nuclear Factor Kappa B (NF-κB), a crucial transcription factor that regulates genes involved in inflammation, immune response, cell survival, and proliferation.
The NF-κB family consists of:
- p65 (RELA): Transcriptional activator
- p50 (NFKB1): Derived from p105
- p52 (NFKB2): Derived from p100
- c-REL, RELB: Other family members
- Neuroinflammation: Central regulator of inflammatory responses in glia
- Cell Survival: Anti-apoptotic gene expression
- Synaptic Plasticity: Regulates learning and memory genes
NF-κB activation in Alzheimer's disease Alzheimer's Disease:
- Chronic neuroinflammation
- Amyloid-beta Aβ induces NF-κB activation
- Regulates inflammatory cytokine expression
NF-κB in Parkinson's disease Parkinson's Disease:
- Activated in dopaminergic neurons
- Mediates neuroinflammation
- Contributes to apoptosis
NF-κB activation in ALS ALS contributes to motor neuron inflammation.
- NF-κB in the nervous system. Nature Reviews Neuroscience, 2006.
- NF-κB and neurodegeneration. Cell Death & Differentiation, 2007.
The study of Nf Κb P105 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- O'Neill LA, Bowie AG. The history of NF-κB: a timescale of discovery and impact. Mol Cell. 2022;82(12):2199-2209.
- Gilmore TD. The NF-κB transcription factor pathway. Oncogene. 2006;25(51):6680-6684.
- Mattson MP. NF-κB in the nervous system. Nat Rev Neurosci. 2006;7(5):337-344.
- Kaltschmidt B, Kaltschmidt C. NF-κB in the nervous system. Cold Spring Harb Perspect Biol. 2009;1(3):a001271.
- Mattson MP, Meffert MK. Roles for NF-κB in nerve cell injury, death, and regeneration. Cell Death Differ. 2007;14(7):1234-1240.
- Shih RH, Wang CY, Yang CM. NF-κB and its role in neuroinflammation. Mol Neurobiol. 2015;52(1):1-15.
- Gabbita SP, et al. Nuclear factor-kappaB: a pivotal transcription factor in Alzheimer's disease. J Alzheimers Dis. 2005;7(1):41-49.
- Ghosh S, Hayden MS. New insights into NF-κB regulation. Cell. 2008;132(5):725-728.
- Zhang Y, et al. NF-κB in Parkinson's disease. Neurobiol Aging. 2018;69:76-82.
- Frakes MS, et al. Microglial activation and neuronal NF-κB in ALS. Acta Neuropathol Commun. 2014;2:160.